These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38297878)

  • 1. Optimal design for inference on the threshold of a biomarker.
    Baldi Antognini A; Frieri R; Rosenberger WF; Zagoraiou M
    Stat Methods Med Res; 2024 Feb; 33(2):321-343. PubMed ID: 38297878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive Randomization Method to Prevent Extreme Instances of Group Size and Covariate Imbalance in Stroke Trials.
    Italiano D; Campbell B; Hill MD; Johns HT; Churilov L
    Stroke; 2024 Aug; 55(8):1962-1972. PubMed ID: 38920051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Pocock and Simon's covariate-adaptive randomization procedures in clinical trials.
    Shan G; Li Y; Lu X; Zhang Y; Wu SS
    BMC Med Res Methodol; 2024 Jan; 24(1):22. PubMed ID: 38273261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population Group.
    Ryeznik Y; Sverdlov O; Hooker AC
    AAPS J; 2018 Jul; 20(5):85. PubMed ID: 30027336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design considerations for two-stage enrichment clinical trials.
    Frieri R; Rosenberger WF; Flournoy N; Lin Z
    Biometrics; 2023 Sep; 79(3):2565-2576. PubMed ID: 36435977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response-adaptive randomization for clinical trials with adjustment for covariate imbalance.
    Ning J; Huang X
    Stat Med; 2010 Jul; 29(17):1761-8. PubMed ID: 20658546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based adaptive randomization procedures for heteroscedasticity of treatment responses.
    Liu Z; Wang X
    Stat Methods Med Res; 2023 Jul; 32(7):1361-1376. PubMed ID: 37165894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point estimation following two-stage adaptive threshold enrichment clinical trials.
    Kimani PK; Todd S; Renfro LA; Stallard N
    Stat Med; 2018 Sep; 37(22):3179-3196. PubMed ID: 29855066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial designs for testing biomarker-based personalized therapies.
    Lai TL; Lavori PW; Shih MC; Sikic BI
    Clin Trials; 2012 Apr; 9(2):141-54. PubMed ID: 22397801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and analysis of biomarker-integrated clinical trials with adaptive threshold detection and flexible patient enrichment.
    Wang T; Wang X; George SL; Zhou H
    J Biopharm Stat; 2020 Nov; 30(6):1060-1076. PubMed ID: 33175640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of Bayesian hierarchical models for adaptive randomization in biomarker-driven phase II studies.
    Barry WT; Perou CM; Marcom PK; Carey LA; Ibrahim JG
    J Biopharm Stat; 2015; 25(1):66-88. PubMed ID: 24836519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simulation study for comparing testing statistics in response-adaptive randomization.
    Gu X; Lee JJ
    BMC Med Res Methodol; 2010 Jun; 10():48. PubMed ID: 20525382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inference under covariate-adaptive randomization: A simulation study.
    Callegaro A; Harsha Shree BS; Karkada N
    Stat Methods Med Res; 2021 Apr; 30(4):1072-1080. PubMed ID: 33504277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size re-estimation in adaptive enrichment design.
    Lin R; Yang Z; Yuan Y; Yin G
    Contemp Clin Trials; 2021 Jan; 100():106216. PubMed ID: 33246098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized adaptive enrichment designs for three-arm trials: learning which subpopulations benefit from different treatments.
    Steingrimsson JA; Betz J; Qian T; Rosenblum M
    Biostatistics; 2021 Apr; 22(2):283-297. PubMed ID: 31420983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-randomization tests in clinical trials.
    Proschan MA; Dodd LE
    Stat Med; 2019 May; 38(12):2292-2302. PubMed ID: 30672002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing a covariate-adaptive randomization procedure in practice.
    Zagoraiou M
    J Biopharm Stat; 2017; 27(5):845-857. PubMed ID: 28166466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.